Tag: Motley Fool

The Afterpay Ltd (ASX: APT) share price is back on form on Thursday and pushing higher.

In afternoon trade, the payments company’s shares are up almost 2% to $123.95.

Can the Afterpay share price go higher?

According to one leading broker, the Afterpay share price may have peaked for the time being.

A note out of Morgans reveals that its analysts have retained their hold rating and cut the price target on its shares to $121.00.

What did Morgans say?

Morgans notes that there was a lot to like from Afterpay’s third quarter update this week.

It was pleased to see its North American underlying sales continue to grow strongly. The broker notes that sales increased 167% on the prior corresponding period or 211% in constant currency.

Morgans also points out that its in-store momentum in the region appears to be accelerating, with March sales annualised implying a run-rate over $225 million. This compares to $180 million during the first half.

Its analysts were also pleased to see revenue margins holding firm and gross loss rates remaining below historical levels.

Another positive in the broker’s eyes was its transaction frequency. It notes that the top 10% of customers globally (by value) are now transacting an average of 33 times per year.

Morgans was also pleased to see that Clearpay is on track to launch in Germany during the first half of FY 2022, along with Afterpay Money in the Australian market.

What didn’t it like?

One thing that appears to have caught the eye of Morgans is that its sales momentum slowed during the third quarter.

In fact, it points out that sales in the US and UK were flat quarter on quarter and down quarter on quarter in the ANZ market.

As a result of this, the broker has lowered its earnings forecasts to reflect lower sales growth assumptions.

Morgans concluded: “APT is a quality business, in our view, but we retain our Hold recommendation on valuation grounds.”

More reading

• Top brokers name 3 ASX shares to sell today
• Is the Afterpay (ASX:APT) share price a buying opportunity right now?
• High-flying ASX tech shares could fall another 90%: fundie
• 5 things to watch on the ASX 200 on Thursday
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Is the Afterpay (ASX:APT) share price fully valued? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3sISzhY

Big brokers have run the ruler on which ASX 200 shares could beat the market. Here are the latest updates on ASX 200 shares that have a buy or buy equivalent rating. 

ASX 200 shares that could go higher

Aristocrat Leisure Ltd (ASX: ALL) 

The gambling machine manufacturer shares have steadily climbed 16% year-to-date to $36.58 and within 2% of its pre-COVID all-time record high. 

Additionally, the reopening of casinos around the world and the strong performance of its digital games segment has helped the company emerge as a strong recovery stock. 

Citi has observed a strong performance according to March surveys. With solid leasing and sales from its Class III premium gaming operations. While its dominant Class II business has seen performance moderate. 

The broker retained its buy rating with a $40.60 target price. 

Corporate Travel Management Ltd (ASX: CTD) 

Corporate Travel shares have caught the attention of Morgan Stanley and Morgans after announcing a positive trading update on Wednesday. The company revealed that it managed to break even for the month of March.

This was following a strong uplift in travel demand. The two brokers were also quick to reiterate a respective overweight and add rating with an average target price of $21.65.

Morgan Stanley observes that this achievement was driven by group domestic travel rising to approximately 60% of pre-COVID revenues. While ANZ bookings have increased to 85% of FY19.

The broker notes that essential travel in the UK and EU should continue to support profitability. There are also positive signs emerging in the United States which may be accelerated by its vaccine rollouts. 

Regis Resources Ltd (ASX: RRL)

The Regis share price is on the move after entering a conditional binding agreement for a stake in IGO Ltd (ASX: IGO) Tropicana Gold Mine on Thursday. 

But before this announcement, Regis provided an upbeat resource update which highlights an 11% increase in ore reserves to 4.0 million ounces and 5% in mineral resources to 8.1 million ounces. 

Morgan Stanley believes the increase in reserves gives around seven years of visibility and should ease investor concerns around mine lives. The broker believes in potential resource conversion and mine life extensions in the near term. 

An overweight rating was maintained with a $4.19 target price. Despite the positive rating, Regis shares are down 25% year-to-date to $2.79 and almost halved since August 2020. 

More reading

• Why Megaport, Pointerra, Regis Resources, & Zip are charging higher
• Are ASX travel shares about to go through a big recovery?
• ASX 200 shares thrown in the bargain bin: Here’s 3 ideas
• Brokers favourite ASX share for the COVID-19 reopening trade
• Why the Regis Resources (ASX:RRL) share price is climbing

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The ASX 200 shares brokers think you should watch out for appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dBwca2

Collins Foods Ltd (ASX: CKF) is not as much of a household name as the KFC (Kentucky Fried Chicken) restaurants that it runs. Collins Food has the license to own and operate KFC stores in Australia, as well as a few other countries. And it has done a pretty good job of carrying out the Colonel’s vision.

Collins Foods shares are up 168% over the past 5 years (not including dividends). They are also up close to 75% over the past 12 months.

The KFC franchise has likely benefitted from a lack of competition in Australia. Compared to the US, where there are dozens of fast food chains, only a few big names truly dominate the national Australian market. These include the famous golden arches in McDonald’s Corp (NYSE: MCD), as well as the Burger King affiliate Hungry Jacks and Dominos Pizza Enterprises Ltd. (ASX: DMP). But it’s relatively safe to say that KFC benefits from being one of the only chicken-focused chains out there. Other competitors in this space are the much-smaller Oporto and Red Rooster brands.

But that could be about to change.

Popeyes: another dirty bird down under?

According to a report in the Australian Financial Review (AFR) today, another US fast food giant with a focus on fried chicken might be about to launch down under. That would be Popeyes Louisiana Kitchen. Popeyes is a US-based franchise owned by Restaurant Brands International Inc (NYSE: QSR). It was founded in 1972 in the Southern state of Louisiana, and specialises in fried chicken.

According to the AFR report, Restaurant Brands International has “contacted Australian food services business and private equity firms to gauge their interest in bank-rolling the launch of Popeyes”.

We could well end up seeing Collins Foods itself take charge of Popeyes. But, as the report notes, this is a long-shot given Collins’s already dominant chicken presence in the Australian market. The report states that ‘bankrollers’ could include Dominos Pizza, Pizza hut-owner Allegro Funds. Or Cravable Brands, which owns Red Rooster and Oporto in Australia.

Either way, it will be an interesting shakeup to watch if Popeyes does enter the Australian fast food scene.

More reading

• 2 strong ASX mid cap shares to buy

Motley Fool contributor Sebastian Bowen owns shares of McDonalds. The Motley Fool Australia has recommended Collins Foods Limited and Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Popeyes down under? Collins Foods’ (ASX:CKF) KFC may have a new competitor appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/32EuWMW

In good news for the Australian economy, Australia’s business activity is almost back to its pre-coronavirus level. That’s according to National Australia Bank Ltd (ASX: NAB) findings in its latest Quarterly Business Survey today. 

The survey reported most industries were experiencing above-average conditions, and companies were confident they would continue to grow. Profitability, trading and employment are all in expansionary territory.

The NAB survey predicted the economy would continue to grow at a healthy rate, despite supports such as JobKeeper winding up. Let’s take a closer look at the survey’s results.

Australian economy ‘improving quickly’

The NAB Quarterly Business Survey found that Australia’s economic recovery from last year’s COVID-19-induced recession is nearing completion.

Capital expenditure expectation strengthened to its highest level since the mid-90s. Capacity utilisation – the instances of businesses working to their maximum capacity – rose to 82.5% in the March quarter. This will most likely support hiring and investment activities.

NAB Group’s chief economist Alan Oster said the findings were “consistent with our forecast that GDP will have fully recovered in [quarter 1]”.

Back in business

Business conditions have improved in all mainland states and territories except South Australia. Western Australia leads the pack, reaching its highest level of business conditions since 2008. 

Business conditions improved in all industries except for a slight easing in retail in the last quarter. However, retail and wholesale reported the strongest conditions across all industries. The construction sector has once again reported the weakest conditions.

Business confidence also improved in all industries except retail, suggesting retail businesses believe they may have already reached pinnacle gains.

Said Oster:

It is worth remembering that conditions provide a guide as to how fast activity is growing, but capacity utilisation provides an indication of the level of activity.

In this quarter, we hit an important milestone; not only does it appear that activity continues to grow at a good pace, but the capacity utilisation index now suggests that the level of activity is back around its pre-COVID level.

The survey also found labour conditions have recorded strong gains as the employment index continues to improve. Expected employment in 3- and 12-months’ time also gained, an encouraging finding in light of JobKeeper coming to an end last month.

While a return to a pre-COVID level of activity would be an important milestone, it would not be a case of ‘mission accomplished’ as we would normally expect the economy to grow over time.

That is why a very welcome aspect of the survey is the strength across all the leading indicators, which suggests that the recovery should continue at a relatively strong pace.

More reading

• Westpac, ANZ, CBA share prices dip after class action for ‘junk’ insurance
• ANZ Bank’s (ASX:ANZ) profit result could get an extra boost: Macquarie
• NAB (ASX:NAB) chair signals ‘rational’ responses to curb booming housing market
• The Westpac (ASX:WBC) share price is the best performing of the big four banks in 2021
• ASX 200 Weekly Wrap: ASX 200 hits new post-COVID high

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post NAB report finds the Australian economy on track to reach pre-COVID level appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3xq6flM

Shares in Redbubble Ltd (ASX: RBL) have continued to spiral downwards throughout the session after the ecommerce company released its third-quarter and year-to-date update. At the time of writing, the Redbubble share price has collapsed 20.51% to $4.38.

Looking at the company’s growth alone doesn’t quite explain the dramatic fall. So, let’s take a look at what exactly could be pushing the Redbubble share price down.

Aspirations don’t fill investors with confidence

Redbubble delivered growth in its gross transaction value, marketplace revenue, and gross profit. That all looks well and good until investors have to stomach compressed margins.

At the end of the day, long-term investing means profits. And ideally, those profits get bigger to deliver increased shareholder return. Well, the Redbubble share price has left its shareholders unsettled by its plans to sacrifice profit margins to deliver its ‘aspirational’ $1.25 billion revenue vision.

“How much?” you might ask. The company expects to reduce its earnings before interest, tax, depreciation, and amortisation (EBITDA) margin to mid-single digits. For comparison, Redbubble’s current margin is 9.5%.

The next question, “For how long?” It’s going to be a rougher ride for the next few years.

After that though, Redbubble expects its margin to range between 10% to 15%. However, that is an aspiration. The problem with aspirations is that shareholders don’t know whether they will come to fruition. But they certainly know returns will now be lower than originally expected in the near term.

So $RBL investors need to go through 3-5 years of increased investment and lower profit margins so in 4-5 years they can make $150M Ebitda 🤔

I don’t think market will like this today…. I could be wrong, but I’m glad we sold out at $7.00 pic.twitter.com/U4I4JHN5qz

— Ron Shamgar (@RonShamgar) April 21, 2021

https://platform.twitter.com/widgets.js

Redbubble share price trade-off

There’s good and bad with today’s announcement. Obviously, the bad news is the Redbubble share price is bleeding out. The concern of increased competition and higher customer acquisition costs could be another.

On the flip side, longer-term it could be a good move for shareholders. If management is able to deliver on their ‘aspirations’ additional shareholder value would be created.

Redbubble indicated the investments will be focused on growing headcount, increasing marketing, and improving its marketplace technology.

More reading

• Why AMP, Challenger, Pilbara Minerals, & Redbubble shares are tumbling lower
• ASX 200 up 0.2%: AMP sinks, Redbubble crashes, Megaport jumps
• Redbubble (ASX:RBL) share price crashes 12% on Q3 update
• 5 things to watch on the ASX 200 on Monday
• Why the Redbubble (ASX:RBL) share price could charge higher today

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Redbubble (ASX:RBL) share price crashes 20% on increased investments appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3tLr4pq

The Chimeric Therapeutics Ltd (ASX: CHM) share price is sliding in mid-afternoon trade. This comes despite the company announcing the successful completion of its CLTX CAR T phase 1 trial.

Established in 2020, Chimeric is developing a breakthrough cancer cell therapy drug for solid tumours. The company uses chlorotoxin, which comes from scorpion venom, to bind and direct T cells to target glioblastoma (GBM). Initial scientific research conducted at the City of Hope Cancer Centre in Los Angeles found promising anti-tumour activity from CAR T therapy.

At the time of writing, the biotechnology company’s shares are going for 29 cents apiece, down 1.6%.

What did Chimeric announce?

Investors appear unfazed by the company’s latest update, sending Chimeric shares lower.

According to its release, Chimeric advised it has passed the first checkpoint in the City of Hope’s phase 1 CLTX CAR T cell clinical trial. All patients in the first group that received the Chlorotoxin CAR T dose have exceeded the 28-day follow-up period without experiencing dose-limiting toxicities.

The dose-escalation study is seeking to assess Chlorotoxin CAR T’s safety and maximum tolerance in participants suffering from recurrent or progressive GBM.

While the first cohort received the minimum dosage limit, Chimeric will now move onto the second dosing level. Patients in this group will be administered via two methods – intratumoral (ICT) and intracranial intraventricular (ICV) at a total dose of 88 x 106 CAR T cells.

Chimeric hopes to recruit between 18 to 36 people with MMP2+ recurrent or progressive GBM across 4 different dose levels. Once the appropriate dosing amount is established, the company will then move to phase 2 trials.

Chimeric chief operating officer, Jennifer Chow commented on the achievement:

We are very pleased to have reached this significant milestone with our CLTX CAR T cell therapy as it enables us to advance the development of this important therapy for patients with progressive or recurrent Glioblastoma.

We look forward to further progressing the development of CLTX CAR T and to providing updates as we seek to bring the promise of cell therapy to life for more patients with cancer.

About the Chimeric share price

Since coming online to the ASX at the start of this year, the Chimeric share price has remained relatively flat. The company’s shares reached an all-time high of 44 cents in late January, before treading lower.

Based on the current share price, Chimeric has a market capitalisation of roughly $57 million.

More reading

• Could this help drive the Sydney Airport (ASX:SYD) share price long term?
• Why Megaport, Pointerra, Regis Resources, & Zip are charging higher
• Why the Spacetalk (ASX:SPA) share price is soaring 6% today
• Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today
• The Rumble Resources (ASX:RTR) share price is up 75% in 3 days

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Chimeric (ASX:CHM) share price edges lower despite positive update appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dCn4SC

Sydney Airport Holdings Pty Ltd (ASX: SYD) shares are edging higher today. This comes as travellers continue rejoicing over the opening of the trans-Tasman bubble allowing travel between Australia and New Zealand for the first time in months.

At the time of writing, the Sydney Airport share price is trading 0.16% higher at $6.08.

Sydney Airport is Australia’s busiest airport, providing aeronautical, retail, property, car rental and parking and ground transport services.

New research poses interesting opportunity for Aussie airports

New research that may be of interest to investors in Sydney Airport shares suggests Australian airports have the potential to one day become national energy producers.

An RMIT University study has found that if large-scale solar panels were installed across Australian airports, they could produce more electricity than is generated by solar panels on 17,000 residential homes.

The paper focused on the solar energy potential of airport rooftop space but also highlighted the potential for ground-based solar panels.

The research indicated that moving forward, governments couldn’t rely on small solar panels used for residential purposes to provide enough electricity to power the entire grid. It further highlighted that doing so — particularly considering in the past there were substantial rebates on home-owner solar panel installation — was potentially an ineffective use of resources.

The research found installing solar panels at 21 airports would generate 10 times more electricity than solar panels installed at 17,000 residential homes while offsetting 151.6 kilotons of greenhouse gasses annually.

What RMIT researchers said

Geospatial scientist at RMIT’s School of Science Dr Chayn Sun said that airports’ large areas and lack of shade made them perfect for solar generation. She said:

More reading

• Are ASX travel shares about to go through a big recovery?
• Brokers favourite ASX share for the COVID-19 reopening trade
• Why Altium, Challenger, Lynas, & Sydney Airport shares are sinking
• Why the Sydney Airport (ASX:SYD) share price is trading lower today
• Leading brokers name 3 ASX shares to sell today

Motley Fool contributor Lucas Radbourne-Pugh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Could this help drive the Sydney Airport (ASX:SYD) share price long term? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3vcKowi

The S&P/ASX 200 Index (ASX: XJO) has rebounded from yesterday’s decline and is pushing higher on Thursday. At the time of writing, the benchmark index is up 0.4% to 7,026.6 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are charging higher:

Megaport Ltd (ASX: MP1)

The Megaport share price has jumped 7% to $12.55. Investors have been buying the elastic interconnection services provider’s shares following the release of its third quarter update. Megaport reported monthly recurring revenue (MRR) of $6.8 million for the three months ended 31 March. This represents a lift of $0.5 million or 8% quarter-on-quarter. This was driven by an increase in its footprint, ports, and customer numbers.

Pointerra Ltd (ASX: 3DP)

The Pointerra share price is surging 23% higher to 64 cents. This follows the release of the 3D geospatial data technology company’s latest quarter update. During the third quarter, the company achieved record quarterly cash receipts from customers of $1.37 million. This was more than double the cash receipts it recorded during the second quarter of FY 2021.

Regis Resources Limited (ASX: RRL)

The Regis Resources share price has climbed 3.5% to $2.84. This morning AngloGold Ashanti Australia Limited (ASX: AGG) gave the greenlight to IGO Limited (ASX: IGO) for its $903 million purchase of a 30% stake in the Tropicana Gold Mine from Regis.

Zip Co Ltd (ASX: Z1P)

The Zip share price has risen almost 3% to $9.00. This gain may have been driven by news that the buy now pay later provider has signed an agreement with Adobe (NASDAQ: ADBE) to become an Accelerate partner in the Adobe Exchange Partner Program. This will make the company the buy now pay later provider of choice for Adobe’s popular e-commerce software, Magento. Zip says the agreement will see its services marketed to thousands of new retail customers across the world.

More reading

• Here’s why the Pointerra (ASX:3DP) share price is rocketing 26% higher
• ASX 200 up 0.2%: AMP sinks, Redbubble crashes, Megaport jumps
• ASX 200 shares thrown in the bargain bin: Here’s 3 ideas
• Zip Pay (ASX:Z1P) share price rising after ‘global leader’ agreement
• Why the Regis Resources (ASX:RRL) share price is climbing

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Pointerra Limited and ZIPCOLTD FPO. The Motley Fool Australia has recommended MEGAPORT FPO and Pointerra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why Megaport, Pointerra, Regis Resources, & Zip are charging higher appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dCvoBE

The Spacetalk Ltd (ASX: SPA) share price is shooting higher today following the release of its quarterly business update.

At the time of writing, the technology company’s shares are fetching 17 cents apiece, up 6.25%.

How did Spacetalk perform in Q3?

Spacetalk shares are lifting off today after the company provided investors with a robust trading update.

For the quarter ending 31 March (Q3), Spacetalk delivered record revenue of $3.9 million, reflecting year-on-year (YoY) growth of 110%. The result was also underpinned by a particularly strong Christmas sales period as COVID-19 restrictions eased.

Spacetalk’s channel partners placed a record number of orders to ensure enough stock was available for customers. Most notably, Spacetalk’s Australian wearable devices segment saw a jump from $0.3 million in Q3 FY20 to $2.4 million in the recent March quarter. Furthermore, this represents an increase of 768% between the 12 months.

Across the Atlantic, the United Kingdom market suffered a setback in revenue. Attaining just $0.2 million, down 36%. The country’s extreme lockdown measures heavily impacted consumer discretionary spend. However, Spacetalk revealed it is currently in discussions with a large mobile network operator and retailers to have a physical presence instore. The company also remains on track for its United States launch this year.

Furthermore, Spacetalk went on to mention about its recent updates such as its partnership with Telstra Corporation Ltd (ASX: TLS), and its LIFE B2B2C model launch.

Additionally, the company declared $4.9 million in cash, with $3 million in drawn debt at the end of the March quarter. This follows Spacetalks’s recent $5 million loan facility to fund inventory purchases, expand geographically, and invest in its brand.

Management commentary

Spacetalk CEO Mark Fortunatow hailed the strong result, saying:

I could not be more excited about the tremendous progress and growth we are seeing in our business; with the Adventurer and original Kids devices benefiting from their strong leadership in a category now gaining mass market appeal, and the growing recognition by aged care, home care and disability industry participants, of the important contribution our LIFE device makes for enabling their residents and customers live life to the fullest.

About the Spacetalk share price

Spacetalk shares have accelerated to almost 90% in the past 12 months, and are up over 50% year-to-date. The company’s share price reached a 52-week high of 22.5 cents in August last year, before moving in circles.

On valuation grounds, Spacetalk presides a market capitalisation of around $28.1 million.

More reading

• Why is the Spacetalk (ASX:SPA) share price jumping 6% today?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Spacetalk (ASX:SPA) share price is soaring 6% today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3n78Qwa

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is soaring today after news the company will acquire clinical research company, MediCaNL Inc.

MediCaNL will design, manage and run the biopharma company’s future clinical trials.

The MGC Pharmaceuticals share price is up 5% on the back of the news. At the time of writing, it’s trading for 6.3 cents. Let’s take a closer look at the announcement MGC made this morning.

MGC’s new acquisition

MGC Pharmaceuticals advised it will acquire MediCaNL, which it has employed for the last 2 years to run clinical trials.

The company said the acquisition would provide immediate savings for the company, cutting MCG’s forecasted clinical trial expenses and streamlining its future preclinical and clinical processes.

MGC said MediCaNL also had 11 other clients and was working on 40 projects and clinical trials. In 2020, it generated nearly $1 million in revenue, with a profit margin of 25%.

The acquisition will cost MGC $6 million worth of its own shares, based on the volume-weighted average price per share 10 days from settlement. MGC will issue 30% of the shares to MediCaNL on acquisition. The other 70% will be issued in 4 instalments over 13 months.

MGC Pharmaceuticals said MediCaNL has worked on 7 investigational new products with the US Federal Drug Administration (FDA). Of these, 2 have been approved and 4 are ongoing. MGC says this shows the company has experience with global pharmaceutical regulators.

MediCaNL is to operate MGC’s clinical trials in accordance with the European Medicines Agency, FDA, ICH Good Clinical Practice, and Israeli health regulations.

MediCaNL’s CEO Nadya Lisodover will work for MGC as chief research officer after the acquisition.

Commentary from management

MGC Pharmaceuticals co-founder and managing director Roby Zomer said:

MediCaNL is led by some of the world’s most renowned doctors and scientists who will be a great asset to the MGC Pharma team.

They operate at the highest levels of quality and integrity, enabling MGC Pharma to establish and nurture stronger relationships with regulators in the years to come as we expand our suite of products and undergo more clinical trials.

MGC Pharmaceuticals share price snapshot

The MGC Pharmaceuticals share price is having a great year so far on the ASX, with today’s news bringing its latest boost.

Currently, the MGC Pharmaceuticals share price is up 220% year-to-date and has lifted 113% over the last 12 months.

The company has a market capitalisation of around $136 million, with approximately 2.2 billion shares outstanding.

More reading

• Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today
• Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dDDWIp